Syra Health Corp. Class A Common Stock
SYRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | -13.3% | 4.8% | -7.4% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $2 |
| Gross Profit | $1 | $1 | $1 | $0 |
| % Margin | 32.9% | 38.7% | 31.7% | 22.7% |
| R&D Expenses | $0 | $0 | $0 | -$0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $0 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -13.8% | -3.2% | -25.5% | -25% |
| Other Income/Exp. Net | $0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -13.4% | -3.3% | -25.4% | -25.1% |
| EPS | -0.019 | -0.01 | -0.065 | -0.069 |
| % Growth | -89% | 84.6% | 6.3% | – |
| EPS Diluted | -0.019 | -0.01 | -0.065 | -0.069 |
| Weighted Avg Shares Out | 12 | 12 | 7 | 7 |
| Weighted Avg Shares Out Dil | 12 | 12 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13.1% | -2.8% | -24.9% | -24.5% |